News Medical on MSN5d
The impact of fall-risk medications on injuries in COPD patients
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...
Commonly prescribed medications can increase fall risk and related injuries in people with COPD
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...
EurekAlert!6d
Commonly prescribed medications increase fall risk and related injuries in people with COPD
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing drugs, according to a new study.
AARP3d
15 Costly Medicare Drugs Selected for Next Round of Price Negotiations
Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...
thecardiologyadvisor.com5d
In COPD, CV Events Increase With Use of Single-Inhaler Triple Therapy
Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.
Armed robbery in Revesby6d
COPD Medications Heighten Fall Risk, Injuries
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing drugs, according to a new study. The study is published in the November 2024 ...
HMPV Case Highlights: How many HMPV cases does India have? Know common symptoms, precautions here
How many cases of HMPV has India reported? The answer is: more than 15. Meanwhile, China said, “...the increase of reports ...
Healthline4d
What a Spirometry Test Score Can Tell You About Your COPD
Share on Pinterest PongMoji/Getty Images Spirometry is an important tool for diagnosing and determining treatment for ... Episodes of COPD exacerbation are also common in severe COPD.
pharmaphorum4d
ICER mulls GSK COPD drugs ahead of next Medicare negotiation
The list for the ... impact" of the two drugs compared to their respective fixed-dose generic alternatives or open generic combinations in patients with moderate to severe COPD.